截至发稿，星湖科技市值为129亿元。 每经头条（nbdtoutiao）——与美元脱钩后，暴涨102倍，揭秘黄金疯涨背后神秘的"无形之手"！专家： 推动金价上涨的逻辑没有变 （记者 王晓波） 每经AI快讯，星湖科技（SH 600866，收盘价：7.74元）10月9日晚间发布公告称，应军先生因工作调整 辞去公司第十一届董事会董事、董事会战略发展与ESG 委员会委员和公司总经理职务。公司董事会同 意聘任闫晓林先生为公司总经理，任期自本次董事会会议审议通过之日起至公司第十一届董事会届满之 日止。 2024年1至12月份，星湖科技的营业收入构成为：食品及饲料添加剂占比92.2%，其他业务占比3.6%， 有机肥料占比2.23%，化学药品原药制造业占比1.97%。 ...

来源：新浪证券-红岸工作室 10月9日，百龙创园涨2.54%，成交额9333.30万元，换手率1.09%，总市值86.44亿元。 异动分析 代糖概念+参股银行+人民币贬值受益+专精特新 1、公司生产的健康甜味剂产品主要为阿洛酮糖，阿洛酮糖是在自然界中天然存在但含量极少的一种稀 有单糖，其甜味及口感与蔗糖相当类似或接近，但其热量却远低于蔗糖，对于肥胖以及糖尿病患者是一 种理想的蔗糖代替物。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 该股筹码平均交易成本为20.44元，近期筹码关注程度减弱；目前股价靠近支撑位20.53，注意支撑位处 反弹，若跌破支撑位则可能会开启一波下跌行情。 公司简介 3、根据202 ...

10月9日，兄弟科技盘中上涨2.34%，截至13:04，报7.43元/股，成交3.47亿元，换手率6.75%，总市值 79.03亿元。 资金流向方面，主力资金净流出3334.52万元，特大单买入396.65万元，占比1.14%，卖出1339.08万元， 占比3.86%；大单买入4432.21万元，占比12.76%，卖出6824.30万元，占比19.65%。 机构持仓方面，截止2025年6月30日，兄弟科技十大流通股东中，国泰中证畜牧养殖ETF（159865）位 居第三大流通股东，持股908.55万股，相比上期增加30.08万股。招商量化精选股票发起式A （001917）、富国中证农业主题ETF（159825）退出十大流通股东之列。 责任编辑：小浪快报 资料显示，兄弟科技股份有限公司位于浙江省海宁市海洲街道学林街1号，成立日期2001年3月19日，上 市日期2011年3月10日，公司主营业务涉及维生素、皮革化学品、香精香料、原料药和催化新材料等产 品的研发、生产与销售。主营业务收入构成为：医药食品58.88%，特种化学品38.21%，其他2.91%。 兄弟科技所属申万行业为：基础化工-化学制品-食品及饲料添加剂 ...

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing growth driven by its health sweetener products, particularly allulose, and benefits from its stake in a rural commercial bank, as well as the depreciation of the RMB [2][3][4]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotics, dietary fibers, and health sweeteners, with a revenue composition of 54.15% from dietary fibers, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8]. - As of August 29, the company had 12,700 shareholders, a decrease of 0.43% from the previous period, with an average of 33,056 circulating shares per shareholder, an increase of 0.43% [8]. - The company was established on December 30, 2005, and went public on April 21, 2021 [8]. Group 2: Financial Performance - For the first half of 2025, the company achieved a revenue of 649 million yuan, representing a year-on-year growth of 22.18%, and a net profit attributable to shareholders of 170 million yuan, up 42.00% year-on-year [8]. - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9]. Group 3: Market Position and Recognition - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which contributes to its financial stability [3]. - The company has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, which is a prestigious title in China for companies excelling in niche markets and innovation [4]. - The company benefits from a 60.62% share of overseas revenue, aided by the depreciation of the RMB [4]. Group 4: Stock Performance and Trading Activity - On September 30, the company's stock rose by 0.20%, with a trading volume of 64.54 million yuan and a turnover rate of 0.77%, bringing the total market capitalization to 8.43 billion yuan [1]. - The average trading cost of the stock is 20.44 yuan, with the current price approaching a resistance level of 20.15 yuan, indicating potential for a price correction if this level is not surpassed [7]. - The main capital inflow for the day was 461,300 yuan, with no significant trends in capital movement observed [5][6].

Company Overview - Star Lake Technology, established on April 18, 1992, and listed on August 18, 1994, is located in Zhaoqing, Guangdong Province. The company specializes in the research, production, and sales of food additives, feed additives, chemical raw materials, and pharmaceutical intermediates [1]. Financial Performance - For the first half of 2025, Star Lake Technology reported a revenue of 8.16 billion yuan, a year-on-year decrease of 3.85%. However, the net profit attributable to shareholders increased by 65.22% to 836 million yuan [2]. - The company has cumulatively distributed 1.57 billion yuan in dividends since its A-share listing, with 1.26 billion yuan distributed over the past three years [3]. Stock Performance - As of September 30, Star Lake Technology's stock price increased by 2.01% to 7.61 yuan per share, with a total market capitalization of 12.644 billion yuan. The stock has risen by 24.96% year-to-date [1]. - The stock's trading volume on September 30 was 124 million yuan, with a turnover rate of 1.31% [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 7% to 44,800, while the average circulating shares per person increased by 7.53% to 24,754 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest, holding 36.2164 million shares, an increase of 25.2508 million shares from the previous period [3].

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing a decline in stock price while benefiting from its unique product offerings and strategic investments, particularly in the context of the depreciating RMB and its recognition as a "specialized, refined, distinctive, and innovative" enterprise [1][2][4]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotic series products, dietary fiber series products, and healthy sweetener products, with a revenue composition of 54.15% from dietary fiber, 28.00% from prebiotics, 13.57% from healthy sweeteners, and 3.91% from other products [8]. - As of August 29, the company had 12,700 shareholders, a decrease of 0.43% from the previous period, with an average of 33,056 circulating shares per shareholder, an increase of 0.43% [8]. - The company has achieved a revenue of 649 million yuan in the first half of 2025, representing a year-on-year growth of 22.18%, and a net profit attributable to shareholders of 170 million yuan, up 42.00% year-on-year [8]. Group 2: Financial Performance - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9]. - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which may provide additional financial benefits [3]. Group 3: Market Position and Trends - The company is recognized as a "specialized, refined, distinctive, and innovative" enterprise, which is a prestigious title for small and medium-sized enterprises in China, indicating strong innovation capabilities and market share [4]. - The company benefits from a 60.62% share of overseas revenue, positively impacted by the depreciation of the RMB [4]. Group 4: Stock Performance and Investor Sentiment - On September 29, the company's stock price fell by 1.77%, with a trading volume of 61.92 million yuan and a turnover rate of 0.73%, leading to a total market capitalization of 8.413 billion yuan [1]. - The stock has an average trading cost of 20.43 yuan, with recent buying activity indicating weak accumulation, and the stock price is approaching a resistance level of 20.11 yuan [7].

资料显示，安徽金禾实业股份有限公司位于安徽省滁州市来安县城东大街127号，成立日期2006年12月 25日，上市日期2011年7月7日，公司主营业务涉及食品添加剂、功能性化工品及各种高端中间体、大宗 化学品等产品的研发、生产和销售,服务于食品饮料、日用消费、医药健康、农业环保及先进制造业等 领域的客户。主营业务收入构成为：食品添加剂48.10%，大宗化学品37.84%，功能性化工品及中间体 5.34%，其他4.08%，电3.27%，医药中间体1.30%，贸易0.08%。 金禾实业所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：代糖概念、合 成生物、煤化工、社保重仓、中盘等。 截至6月30日，金禾实业股东户数3.41万，较上期增加3.26%；人均流通股16640股，较上期减少3.18%。 2025年1月-6月，金禾实业实现营业收入24.44亿元，同比减少3.73%；归母净利润3.34亿元，同比增长 35.29%。 分红方面，金禾实业A股上市后累计派现30.17亿元。近三年，累计派现10.05亿元。 9月26日，金禾实业盘中上涨2.40%，截至13:00，报21.34元/股，成交7072. ...

Company Overview - Brother Technology Co., Ltd. is located in Haining, Zhejiang Province, established on March 19, 2001, and listed on March 10, 2011. The company specializes in the research, production, and sales of products including vitamins, leather chemicals, fragrances, raw pharmaceuticals, and catalytic new materials [1][2]. Financial Performance - For the first half of 2025, Brother Technology achieved operating revenue of 1.811 billion yuan, representing a year-on-year growth of 3.45%. The net profit attributable to the parent company was 64.541 million yuan, showing a significant year-on-year increase of 357.17% [2]. - Since its A-share listing, Brother Technology has distributed a total of 390 million yuan in dividends, with 106 million yuan distributed over the past three years [3]. Stock Performance - As of September 25, Brother Technology's stock price increased by 2.13%, reaching 7.67 yuan per share, with a total market capitalization of 8.159 billion yuan. The stock has risen by 80.47% year-to-date, with a 14.99% increase over the past 20 days [1]. - The company has appeared on the trading leaderboard eight times this year, with the most recent appearance on September 18, where it recorded a net buy of -82.5761 million yuan [1]. Shareholder Information - As of June 30, the number of shareholders for Brother Technology was 62,900, an increase of 19.32% from the previous period. The average number of circulating shares per person decreased by 16.19% to 11,153 shares [2]. - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF ranked as the third-largest shareholder, holding 9.0855 million shares, an increase of 300,800 shares from the previous period [3]. Industry Classification - Brother Technology is classified under the Shenwan industry as Basic Chemicals - Chemical Products - Food and Feed Additives. The company is also associated with several concept sectors, including PEEK concept, pre-profit growth, small-cap stocks, and Sino-Russian trade concepts [2].

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing positive market movements due to its involvement in the rare sugar industry, particularly with allulose, and benefits from its stake in a rural commercial bank amidst the depreciation of the RMB [2][3][4]. Company Overview - Shandong Bailong Chuangyuan was established on December 30, 2005, and went public on April 21, 2021. The company specializes in the research, production, and sales of prebiotic products, dietary fiber products, and healthy sweeteners [8]. - The company's main revenue sources are dietary fiber series (54.15%), prebiotic series (28.00%), healthy sweeteners (13.57%), and others (3.91%) [8]. Financial Performance - For the first half of 2025, the company achieved a revenue of 649 million yuan, representing a year-on-year growth of 22.18%, and a net profit attributable to shareholders of 170 million yuan, up 42.00% year-on-year [8]. - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9]. Market Position and Recognition - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which is expected to benefit from the depreciation of the RMB [3][4]. - It has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, which is a prestigious title for small and medium-sized enterprises in China [4]. Stock Performance - On September 24, the company's stock rose by 1.08%, with a trading volume of 121 million yuan and a turnover rate of 1.40%, bringing the total market capitalization to 8.631 billion yuan [1]. - The average trading cost of the stock is 20.43 yuan, with the current price near a support level of 20.53 yuan [7]. Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Penghua New Emerging Industry Mixed Fund and Hong Kong Central Clearing Limited, with some new entrants among the top ten shareholders [10].

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing positive market movements due to its involvement in the sugar substitute sector, its stake in a rural commercial bank, and benefits from the depreciation of the RMB, alongside its recognition as a "specialized, refined, distinctive, and innovative" enterprise [2][4]. Company Overview - Shandong Bailong Chuangyuan was established on December 30, 2005, and went public on April 21, 2021. Its main business includes the research, production, and sales of prebiotics, dietary fibers, starch sugars, and healthy sweeteners [8]. - The company's revenue composition is as follows: dietary fibers 54.15%, prebiotics 28.00%, healthy sweeteners 13.57%, and others 3.91% [8]. Financial Performance - For the first half of 2025, the company achieved a revenue of 649 million, representing a year-on-year growth of 22.18%, and a net profit attributable to shareholders of 170 million, with a growth of 42.00% [8]. - The company has distributed a total of 183 million in dividends since its A-share listing, with 172 million distributed over the past three years [9]. Shareholding and Market Activity - As of June 30, 2025, the top ten circulating shareholders include notable funds such as Penghua New Emerging Industries Mixed Fund and Hong Kong Central Clearing Limited, indicating increased institutional interest [10]. - The stock has seen a net inflow of 7.34 million today, with a total market capitalization of 8.54 billion [5][6]. Industry Context - The company is categorized under the basic chemical industry, specifically in food and feed additives, and is part of several concept sectors including sugar substitutes and value growth [8]. - The recognition as a "specialized, refined, distinctive, and innovative" enterprise enhances its competitive edge and stability within the industry [4].